Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2003 1
2004 9
2005 1
2006 2
2008 3
2009 3
2010 4
2011 7
2012 2
2013 5
2014 9
2015 9
2016 5
2017 6
2018 4
2019 9
2020 12
2021 9
2022 11
2023 10
2024 9
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Similar articles for PMID: 34385343

101 results

Results by year

Filters applied: . Clear all
Page 1
Phase I Study of 99mTc-ADAPT6, a Scaffold Protein-Based Probe for Visualization of HER2 Expression in Breast Cancer.
Bragina O, von Witting E, Garousi J, Zelchan R, Sandström M, Orlova A, Medvedeva A, Doroshenko A, Vorobyeva A, Lindbo S, Borin J, Tarabanovskaya N, Sörensen J, Hober S, Chernov V, Tolmachev V. Bragina O, et al. J Nucl Med. 2021 Apr;62(4):493-499. doi: 10.2967/jnumed.120.248799. Epub 2020 Aug 17. J Nucl Med. 2021. PMID: 32817142 Free PMC article. Clinical Trial.
Comparative Preclinical Evaluation of Peptide-Based Chelators for the Labeling of DARPin G3 with 99mTc for Radionuclide Imaging of HER2 Expression in Cancer.
Larkina M, Plotnikov E, Bezverkhniaia E, Shabanova Y, Tretyakova M, Yuldasheva F, Zelchan R, Schulga A, Konovalova E, Vorobyeva A, Garousi J, Gräslund T, Belousov M, Tolmachev V, Deyev S. Larkina M, et al. Int J Mol Sci. 2022 Nov 3;23(21):13443. doi: 10.3390/ijms232113443. Int J Mol Sci. 2022. PMID: 36362226 Free PMC article.
Comparative Preclinical Evaluation of HYNIC-Modified Designed Ankyrin Repeat Proteins G3 for the 99mTc-Based Imaging of HER2-Expressing Malignant Tumors.
Larkina M, Varvashenya R, Yuldasheva F, Plotnikov E, Bezverkhniaia E, Tretyakova M, Zelchan R, Schulga A, Konovalova E, Vorobyeva A, Belousov M, Orlova A, Tolmachev V, Deyev S. Larkina M, et al. Mol Pharm. 2024 Apr 1;21(4):1919-1932. doi: 10.1021/acs.molpharmaceut.3c01173. Mol Pharm. 2024. PMID: 38557163
Development of the designed ankyrin repeat protein (DARPin) G3 for HER2 molecular imaging.
Goldstein R, Sosabowski J, Livanos M, Leyton J, Vigor K, Bhavsar G, Nagy-Davidescu G, Rashid M, Miranda E, Yeung J, Tolner B, Plückthun A, Mather S, Meyer T, Chester K. Goldstein R, et al. Eur J Nucl Med Mol Imaging. 2015 Feb;42(2):288-301. doi: 10.1007/s00259-014-2940-2. Epub 2014 Nov 13. Eur J Nucl Med Mol Imaging. 2015. PMID: 25391547 Free PMC article.
101 results